<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Terapevticheskii arkhiv</journal-id><journal-title-group><journal-title xml:lang="en">Terapevticheskii arkhiv</journal-title><trans-title-group xml:lang="ru"><trans-title>Терапевтический архив</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0040-3660</issn><issn publication-format="electronic">2309-5342</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">60293</article-id><article-id pub-id-type="doi">10.26442/00403660.2020.12.200435</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Clinical case of combined genetic pathology in a patient</article-title><trans-title-group xml:lang="ru"><trans-title>Клинический случай сочетанной генетической патологии (семейная гиперхолестеринемия – синдром Жильбера)</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3528-7983</contrib-id><name-alternatives><name xml:lang="en"><surname>Losik</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Лосик</surname><given-names>Екатерина Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>м.н., врач-кардиолог</p></bio><email>iryakushina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6818-0840</contrib-id><name-alternatives><name xml:lang="en"><surname>Yakushina</surname><given-names>I. I.</given-names></name><name xml:lang="ru"><surname>Якушина</surname><given-names>Ирина Ивановна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>к.м.н., доц. каф.</p></bio><email>iryakushina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6946-7771</contrib-id><name-alternatives><name xml:lang="en"><surname>Skhirtladze</surname><given-names>M. R.</given-names></name><name xml:lang="ru"><surname>Схиртладзе</surname><given-names>Манана Ревазовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>к.м.н., зав. отд-нием</p></bio><email>iryakushina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1900-2885</contrib-id><name-alternatives><name xml:lang="en"><surname>Balahonova</surname><given-names>N. P.</given-names></name><name xml:lang="ru"><surname>Балахонова</surname><given-names>Надежда Павловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>к.м.н., врач-кардиолог высшей категории</p></bio><email>iryakushina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-8023-4410</contrib-id><name-alternatives><name xml:lang="en"><surname>Kerchev</surname><given-names>V. V.</given-names></name><name xml:lang="ru"><surname>Керчев</surname><given-names>Виктор Васильевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>врач-ординатор</p></bio><email>iryakushina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1135-6558</contrib-id><name-alternatives><name xml:lang="en"><surname>Garanina</surname><given-names>I. A.</given-names></name><name xml:lang="ru"><surname>Гаранина</surname><given-names>Ирина Андреевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="ru"><p>студентка</p></bio><email>iryakushina@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Sechenov First Moscow State Medical University (Sechenov University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2020-12-15" publication-format="electronic"><day>15</day><month>12</month><year>2020</year></pub-date><volume>92</volume><issue>12</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>180</fpage><lpage>184</lpage><history><date date-type="received" iso-8601-date="2021-02-07"><day>07</day><month>02</month><year>2021</year></date><date date-type="accepted" iso-8601-date="2021-02-07"><day>07</day><month>02</month><year>2021</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://ter-arkhiv.ru/0040-3660/article/view/60293">https://ter-arkhiv.ru/0040-3660/article/view/60293</self-uri><abstract xml:lang="en"><p>Family hypercholesterolemia (HSX) is a form of genetically deterministic increase in blood lipid levels associated with a high risk of cardiovascular disease, usually at a young age. HSX is a common genetic disease found in the general population in most countries in 1:500 people. Clinically xantomas are found in achilles tendor and wrist flexors, lipoid arc of the cornea, concentration of total cholesterol and low-density lipoproteins is 4.9–11.6 mmol/l. Gilbert’s syndrome is a hereditary benign hyperbilirubinium, associated with a decrease in the functional activity of the liver enzyme uridinfosfat-glucuronosil transferase. Clinically, this syndrome appers in intermittent jaundice, which is provoked by physical activity, consumption of alcoholic beverages, insulation and an increase in the level of indirect bilirubin within 20–100 micromol/ml. The article presents a rare clinical case of genetic combination of HSC SSC and Gilbert syndrome a young patient has and discusses the elevated bilirubin levels protective role in the atherosclerosis progression in Gilbert syndrome.</p></abstract><trans-abstract xml:lang="ru"><p>Семейная гиперхолестеринемия (СГХС) является формой генетически детерминированного повышения уровня липидов в крови, ассоциированной с высоким риском сердечно-сосудистых заболеваний, как правило, в молодом возрасте. СГХС – распространенное моногенное заболевание, встречающееся в гетерозиготной форме в общей популяции большинства стран у 1:500 человек, что делает его важной проблемой общественного здравоохранения. Клинически у пациентов обнаруживаются ксантомы в области ахиллова сухожилия и разгибателей кисти, ксантелазмы, липоидная дуга роговицы, концентрация общего холестерина и липопротеинов низкой плотности составляет 4,9–11,6 ммоль/л. Синдром Жильбера – наследственная доброкачественная гипербилирубинемия, связанная со снижением уровня функциональной активности фермента печени уридиндифосфат-глюкуронозилтрансферазы. Клинически данный синдром проявляется интермиттирующей желтухой, которая провоцируется физической нагрузкой, употреблением алкогольных напитков, инсоляцией и повышением уровня непрямого билирубина в пределах 20–100 мкмоль/мл. Распространенность синдрома Жильбера составляет около 5–10% населения, а число носителей достигает 40%. В статье представлен редкий клинический случай генетического сочетания СГХС и синдрома Жильбера у молодого пациента и обсуждена протективная роль повышенного уровня билирубина в прогрессировании атеросклероза при синдроме Жильбера.</p></trans-abstract><kwd-group xml:lang="en"><kwd>gene mutation</kwd><kwd>genetic testing</kwd><kwd>familial hypercholesterolemia</kwd><kwd>Gilbert’s syndrome</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>мутация гена</kwd><kwd>генетическое тестирование</kwd><kwd>семейная гиперхолестеринемия</kwd><kwd>синдром Жильбера</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Watts GF, Gidding S, Wierzbicki AS, et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol. 2014;171(3):309-24. doi: 10.1016/j.ijcard.2013.11.025</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Sharifi M, Rakhit RD, Humphries SE, Nair D. Cardiovascular risk stratification in familial hypercholesterolaemia. Heart. 2016;102(13):1003-8. doi: 10.1136/heartjnl-2015-308845</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Marks D, Thorogood M, Neil HA, Humphries SE. A Review on the Diagnosis, Natural History, and Treatment of Familial Hypercholesterolaemia. Atherosclerosis. 2003;168(1):1-14. doi: 10.1016/S0021-9150(02)00330-1</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Innerarity TL, Mahley RW, Weisgraber KH, et al. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholesterolemia. J Lipid Res. 1990;31(8):1337-49.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Vítek L. Bilirubin and Atherosclerotic Diseases. Physiol. 2017;66(1):11-20. doi: 10.33549/physiolres.933581</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Schwertner HA, Vitek L. Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: possible protective effects and therapeutic applications of bilirubin. Atherosclerosis. 2008;198:1-11. doi: 10.1016/j.atherosclerosis.2008.01.001</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Claridge LC, Armstrong MJ, Booth C, et al. Gilbert’s syndrome. BMJ. 2011;342:d2293. doi: 10.1136/bmj.d2293</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Farheen S, Sengupta S, Santra A, et al. Gilbert’s syndrome: High frequency of the (TA) 7 TAA allele in India and its interaction with a novel CAT insertion in promoter of the gene for bilirubin UDP-glucuronosyltransferase 1 gene. World J Gastroenterol. 2006;12(14):2269-75. doi: 10.3748/wjg.v12.i14.2269</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Strassburg CP, Oldhafer K, Manns MP, Tukey RH. Differential expression of the UGT1A locus in human liver, biliary and gastric tissue: identification of UGT1A7 and UGT1A10 transcripts in extrahepatic tissue. Molec Pharm. 1997;52(2):212-20. doi: 10.1124/mol.52.2.212</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Van Es HH, Bout A, Liu J, et al. Assignment of the human UDP glucuronosyltransferase gene (UGT1A1) to chromosome region 2q37. Cytogenet Cell Genet. 1993:63(2);114-6. doi: 10.1159/000133513</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Nordestgaard BG, Chapman MJ, Humphries SE, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34(45):3478-90a. doi: 10.1093/eurheartj/eht273</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Клеменов А.В. Наследственные нарушения соединительной ткани: нерешенные вопросы и дискуссионные проблемы. Мед. вестн. Северного Кавказа. 2016;11(2):358-63 [Klemenov AV. Hereditary connective tissue disorders: unresolved issues and debatable issues. Medicinskij vestnik Severnogo Kavkaza. 2016;11(2):358-63 (In Russ.)]. doi: 10.14300/mnnc.2016.11078</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Hanihara T, Ishida H. Os Incae: Variation In Frequency In Major Human Population Groups. J Anat. 2001;198:137-52. doi: 10.1046/j.1469-7580.2001.19820137.x</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Rauh G, Keller C, Schuster H, et al. Familial defective apolipoprotein B-100: a common cause of primary hypercholesterolemia. Clin Invest. 1992;70:77-84.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Henderson R, O’Kane M, McGilligan V, Watterson S. The genetics and screening of familial hypercholesterolaemia. J Biomed Sci. 2016;23:39. doi: 10.1186/s12929-016-0256-1</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Chlebus K, Cybulska B, Gruchała M, et al. Prevalence, diagnosis, and treatment of familial hypercholesterolaemia in outpatient practices in Poland. Kardiol Pol. 2018;76(6):960-7. doi: 10.5603/KP.a2018.0053</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Umans-Eckenhausen MA, Defesche JC, Sijbrands EJ, et al. Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands. Lancet. 2001;357(9251):165-8.</mixed-citation></ref></ref-list></back></article>
